These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7396470)

  • 21. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
    Coulthard KP; Peckham DG; Conway SP; Smith CA; Bell J; Turnidge J
    J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of infusion systems on pharmacokinetic parameters of tobramycin in newborn infants.
    Nahata MC
    Chemotherapy; 1988; 34(5):361-6. PubMed ID: 3180903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective.
    Massey KL; Hendeles L; Neims A
    J Pediatr; 1986 Nov; 109(5):897-901. PubMed ID: 3095524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization.
    van Velzen AJ; Bos AC; Touw DJ; Tiddens HA; Heijerman HG; Janssens HM
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):273-80. PubMed ID: 26716357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of subcutaneous tobramycin].
    Babinet P; Tancrede C; Bricaire F; Mariel C; Goulon M
    Nouv Presse Med; 1976 Nov; 5(39):2640. PubMed ID: 995605
    [No Abstract]   [Full Text] [Related]  

  • 27. [Build up of a given concentration of tobramycin and sisomycin in the blood of young children by the intravenous infusion of the antibiotics according to a calculated regimen].
    Firsov AA; Pankova GF
    Antibiotiki; 1982 Nov; 27(11):830-5. PubMed ID: 6758682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tobramycin therapy--two or three doses per day?
    Lilliestierna H; Alestig K; Holm S
    Scand J Infect Dis; 1985; 17(3):323-5. PubMed ID: 4059871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosage and dosage interval of tobramycin in the newborn.
    Eitelberger F; Hohenauer L; Sommer R
    Br J Clin Pract Suppl; 1988 Feb; 57():49-53. PubMed ID: 3140877
    [No Abstract]   [Full Text] [Related]  

  • 30. Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation.
    Sung L; Dupuis LL; Bliss B; Taddio A; Abdolell M; Allen U; Rolland M; Tong A; Taylor T; Doyle J
    J Natl Cancer Inst; 2003 Dec; 95(24):1869-77. PubMed ID: 14679156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen.
    Kamel Mohamed OH; Wahba IM; Watnick S; Earle SB; Bennett WM; Ayres JW; Munar MY
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):694-9. PubMed ID: 17699484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parenteral administration of tobramycin for pulmonary exacerbations in cystic fibrosis patients: toxicity, serum levels and efficacy.
    Braccini G; Lori I; Neri AS; Festini F; Pela I; Ciuti R; Boni V; Zavataro L; Braggion C; De Martino M; Taccetti G
    J Chemother; 2009 Feb; 21(1):101-4. PubMed ID: 19297282
    [No Abstract]   [Full Text] [Related]  

  • 33. Initial aminoglycoside levels in the critically ill.
    Summer WR; Michael JR; Lipsky JJ
    Crit Care Med; 1983 Dec; 11(12):948-50. PubMed ID: 6641254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis.
    Bates RD; Nahata MC; Jones JW; McCoy K; Young G; Cox S; Barson WJ
    Chest; 1997 Nov; 112(5):1208-13. PubMed ID: 9367459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic serum trough concentrations after administration of nebulized tobramycin.
    Kahler DA; Schowengerdt KO; Fricker FJ; Mansfield M; Visner GA; Faro A
    Pharmacotherapy; 2003 Apr; 23(4):543-5. PubMed ID: 12680485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic blood concentrations in patients successfully treated with tobramycin.
    Fiala M; Chatterjee SN
    Postgrad Med J; 1981 Sep; 57(671):548-51. PubMed ID: 7329892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobramycin pharmacokinetics in children with febrile neutropenia undergoing stem cell transplantation: once-daily versus thrice-daily administration.
    Dupuis LL; Sung L; Taylor T; Abdolell M; Allen U; Doyle J; Taddio A
    Pharmacotherapy; 2004 May; 24(5):564-73. PubMed ID: 15162890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tobramycin dosing in cystic fibrosis.
    Smyth A; Touw D; Tan KH; Bertenshaw C; Stableforth D
    Lancet; 2005 May 21-27; 365(9473):1767-8. PubMed ID: 15910946
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical experience with tobramycin in the treatment of infections due to gram-negative bacilli.
    Carmalt ED; Cortez LM; Rosenblatt JE
    Am J Med Sci; 1976; 271(3):285-95. PubMed ID: 820195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.